Clinical Trial: Rare Kidney Stone Consortium Biobank
Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Observational
Official Title: Rare Kidney Stone Consortium Biobank, Rare Diseases Clinical Research Network
Brief Summary: This study is being done to obtain samples from patients with primary hyperoxaluria, cystinuria, adenine phosphoribosyl transferase (APRT) deficiency, and Dent disease, and from their family members, for use in future research.
Detailed Summary: Biologic samples will be stored in the biobank from well characterized patients with primary hyperoxaluria, cystinuria, APRT deficiency, and Dent disease, and from their family members, for use in future research. This will help to advance our understanding of disease expression and the factors associated with kidney injury in these four diseases with the overall goal of developing new treatments to preserve kidney function and reduce nephrocalcinosis and stone formation.
Sponsor: Mayo Clinic
Current Primary Outcome: Number of samples stored in tissue bank [ Time Frame: 4 years ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Mayo Clinic
Dates:
Date Received: December 30, 2013
Date Started: May 2013
Date Completion: June 2020
Last Updated: July 5, 2016
Last Verified: July 2016